Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram
Prostate Cancer & Prostatic Diseases, 06/20/2012
Kutikov A et al. – Integrating clinicopathological variables with comorbid conditions in a competing–risks model affords quantification and comparison of relative probabilities of prostate cancer–specific mortality and non–prostate cancer death following treatment. The model thereby facilitates an individualized approach for counseling patients regarding prostate cancer management.